SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease.

There has been great interest in the prospects of using single-nucleotide polymorphisms (SNPs) in the search for complex disease genes, and several initiatives devoted to the identification and mapping of SNPs throughout the human genome are currently underway. However, actual data investigating the use of SNPs for identification of complex disease genes are scarce. To begin to look at issues surrounding the use of SNPs in complex disease studies, we have initiated a collaborative SNP mapping study around APOE, the well-established susceptibility gene for late-onset Alzheimer disease (AD). Sixty SNPs in a 1.5-Mb region surrounding APOE were genotyped in samples of unrelated cases of AD, in controls, and in families with AD. Standard tests were conducted to look for association of SNP alleles with AD, in cases and controls. We also used family-based association analyses, including recently developed methods to look for haplotype association. Evidence of association (P</=.05) was identified for 7 of 13 SNPs, including the APOE-4 polymorphism, spanning 40 kb on either side of APOE. As expected, very strong evidence for association with AD was seen for the APOE-4 polymorphism, as well as for two other SNPs that lie <16 kb from APOE. Haplotype analysis using family data increased significance over that seen in single-locus tests for some of the markers, and, for these data, improved localization of the gene. Our results demonstrate that associations can be detected at SNPs near a complex disease gene. We found that a high density of markers will be necessary in order to have a good chance of including SNPs with detectable levels of allelic association with the disease mutation, and statistical analysis based on haplotypes can provide additional information with respect to tests of significance and fine localization of complex disease genes.

[1]  Thomas D. Schmittgen,et al.  Real-Time Quantitative PCR , 2002 .

[2]  D. Valle,et al.  Online Mendelian Inheritance In Man (OMIM) , 2000, Human mutation.

[3]  J. Gilbert,et al.  Analysis of association at single nucleotide polymorphisms in the APOE region. , 2000, Genomics.

[4]  R. Hegerl,et al.  The Tom Core Complex , 1999, The Journal of cell biology.

[5]  D. Clayton,et al.  A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. , 1999, American journal of human genetics.

[6]  S. Pulst.  Genetic linkage analysis. , 1999 .

[7]  E. Marshall.  Drug Firms to Create Public Database of Genetic Mutations , 1999, Science.

[8]  M. Boehnke,et al.  Genetic linkage analysis of complex genetic traits by using affected sibling pairs. , 1998, Biometrics.

[9]  L. Brooks,et al.  A DNA polymorphism discovery resource for research on human genetic variation. , 1998, Genome research.

[10]  E Lai,et al.  A 4-Mb high-density single nucleotide polymorphism-based map around human APOE. , 1998, Genomics.

[11]  L. Ashworth,et al.  Sequencing of 42kb of the APO E-C2 gene cluster reveals a new gene: PEREC1. , 1998, DNA sequence : the journal of DNA sequencing and mapping.

[12]  J. Haines,et al.  Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. , 1997, JAMA.

[13]  B S Weir,et al.  Tests for linkage and association in nuclear families. , 1997, American journal of human genetics.

[14]  D E Weeks,et al.  True and false positive peaks in genomewide scans: applications of length-biased sampling to linkage mapping. , 1997, American journal of human genetics.

[15]  J. Haines,et al.  ApoE-4 and Age at Onset of Alzheimer's Disease , 1997, Neurology.

[16]  O. Faergeman,et al.  The apolipoprotein E polymorphism in Greenland Inuit in its global perspective , 1996, Human Genetics.

[17]  N Risch,et al.  The Future of Genetic Studies of Complex Human Diseases , 1996, Science.

[18]  Tom Slezak,et al.  An integrated metric physical map of human chromosome 19 , 1995, Nature Genetics.

[19]  D. Rubinsztein,et al.  Arginine residues at codons 112 and 158 in the apolipoprotein E gene correspond to the ancestral state in humans. , 1995, Atherosclerosis.

[20]  K H Buetow,et al.  A comprehensive human linkage map with centimorgan density. Cooperative Human Linkage Center (CHLC). , 1994, Science.

[21]  A. M. Saunders,et al.  Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.

[22]  A D Roses,et al.  Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  M. Pericak-Vance,et al.  Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases , 1993, The Lancet.

[24]  M. Pericak-Vance,et al.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Haines,et al.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.

[26]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Pericak-Vance,et al.  Linkage studies in familial Alzheimer disease: evidence for chromosome 19 linkage. , 1991, American journal of human genetics.

[28]  J. Ott,et al.  Strategies for multilocus linkage analysis in humans. , 1984, Proceedings of the National Academy of Sciences of the United States of America.